Digital Healtcare solutions
Product Description
Aptar Pharma
-
FR
-
2015On CPHI since
-
5000+Employees
Company types
Primary activities
Categories
Aptar Pharma
-
FR
-
2015On CPHI since
-
5000+Employees
Company types
Primary activities
More Products from Aptar Pharma (44)
-
Product Small Volume Parenteral Stoppers
Aptar Pharma's Serum Stoppers offer optimal protection and drug delivery for blowback and non-blowback vials. -
Product Large Volume Parenteral Stoppers
Aptar Pharma's Infusion Stoppers provide optimal protection and drug delivery for infusion bottles, meeting multi-piercing needs and streamlining manufacturing processes. -
Product Plungers
Aptar Pharma is a global leader in elastomeric Plungers for Pre-Filled Syringes, providing safe and high-quality solutions for injectable developments. -
Product AdhereIT®
AdhereIT® is a connected medical device that enhances patient adherence for self-injecting medication. It supports training and autoinjector devices, alleviating anxieties and promoting proper usage. Through multisensory feedback and app features, AdhereIT® enables patients to start treatment sooner an... -
Product Training Devices
Noble's patient-centric training devices, mimic real drug delivery devices to improve self-administered therapies. They enhance patient experience, promote adherence, and boost health outcomes. These fully resettable and reusable devices offer a realistic drug delivery simulation, allowing patients to ... -
Product PADA – Starter Kit for Pre-Clinical Pulmonary Research in Mice
PADA (Powder Administration Device for Animals) is a specialized kit by Aptar Pharma for pre-clinical pulmonary research. It allows precise and efficient powder delivery to mouse lungs, aiding early-stage drug development for asthma, COPD, lung cancers, and cystic fibrosis. -
Product Dermal Solutions
At Aptar Pharma, we meet evolving dermal drug delivery needs, prioritizing patient safety and risk reduction. With the widest range of Airless devices, we support the increasing demand for dermal drug delivery solutions.
-
Product Eye Care Solutions
Aptar Pharma's extensive portfolio of eye care solutions, boasting more than 400 market references, has solidified its position as the leading platform for ophthalmic drug delivery. With a constant focus on innovation and continuous growth, Aptar Pharma has become the preferred choice for meeting the n... -
Product Injectables Solutions
Aptar Pharma is renowned for delivering top-quality injectable components designed for applications such as Pre-Filled Syringe, vial, and cartridge.
-
Product Nasal Solutions
Aptar Pharma is a renowned producer of proprietary nasal device systems, specializing in Unidose, Bidose, and multi-dose options, known for their exceptional quality and reliability.
-
Product Other Solutions
Aptar Pharma offers diverse delivery options and aims to accelerate your drug development process while minimizing risks. Their solutions encompass oral, ear and throat, buccal, vaginal, and anal treatments.
-
Product Pulmonary Solutions & Respiratory Solutions
Aptar Pharma is a global leader in pulmonary drug delivery devices for asthma and COPD. We offer a wide range of pMDI technology platforms, including metering valves, dose counters, BAIs, and DPIs, designed to optimize treatment and management for patients.
Aptar Pharma resources (3)
-
Video Innovations in Inhalation
Aptar Pharma's presentation entitled "Innovations in Inhalation" explores the current extensive portfolio of high-quality OINDP (Orally Inhaled and Nasal Drug Products) delivery devices. The presentation also highlights Aptar Pharma's comprehensive services which support respiratory drug development, including device selection, formulation development, analytical methods, and regulatory support. A key focus of the talk is the introduction of Orbital, an innovative high payload DPI system designed to enhance drug delivery efficiency and patient compliance. This discussion aims to showcase Aptar Pharma's latest advancements in inhalation technology, emphasizing their commitment to improving patient care through innovative drug delivery systems. -
Video The Pharma Challenge With Scope 3 Emissions – Collaborative Ways to Reduce Our CO2 Footprint
Big Pharma reports that up to over 90% of their CO2 emissions are scope 3. This is not only a huge burden but also the most difficult part to influence for pharmaceutical industry. However, there are ways to manage and collaborate in the industry. Christophe Marie from Aptar Group will highlight how Aptar implemented specific targets with partners and suppliers to tackle the scope 3 challenge, coming from a consumer market perspective, extrapolating into the pharmaceutical business. Also, when talking about products we are increasingly facing requests to minimize our CO2 footprint in Pharma. A great example for collaborative approaches helping to de-risk and accelerate our clients’ low GWP pressurized Metered Dose Inhaler (pMDI) programs will be illustrated by Chris Baron, based on the transition of the current pMDIs to alternative low GWP propellant technologies. Join Christophe Marie and Chris Baron at CPHI to learn how Aptar Pharma supports more sustainable product -
Brochure Aptar Pharma Brochure
Aptar Pharma Brochure
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance